UBS AM
CMRX

UBS AM’s Chimerix, Inc. CMRX Stock Holding History

UBS AM’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-84,294
Closed -$163K – 2752
2022
Q3 		$163K Sell
84,294
-17,278
-17% -$38.8K ﹤0.01% 2639
2022
Q2 		$211K Buy
101,572
+378
+0.4% +$1.21K ﹤0.01% 2570
2022
Q1 		$463K Hold
101,194
– – ﹤0.01% 2487
2021
Q4 		$651K Buy
101,194
+3,800
+4% +$22.8K ﹤0.01% 2440
2021
Q3 		$603K Buy
97,394
+5,100
+6% +$35.1K ﹤0.01% 2422
2021
Q2 		$738K Buy
+92,294
New +$767K ﹤0.01% 2366
2016
Q4 		– Sell
-909,773
Closed -$5.04M – 2683
2016
Q3 		$5.04M Sell
909,773
-81,708
-8% -$374K 0.01% 1018
2016
Q2 		$3.9M Sell
991,481
-2,264,710
-70% -$11.2M ﹤0.01% 1091
2016
Q1 		$16.6M Buy
3,256,191
+156,969
+5% +$1.02M 0.02% 722
2015
Q4 		$27.7M Sell
3,099,222
-252,713
-8% -$9.1M 0.03% 531
2015
Q3 		$128M Sell
3,351,935
-227,451
-6% -$11.2M 0.14% 161
2015
Q2 		$165M Buy
3,579,386
+177,123
+5% +$7.1M 0.16% 140
2015
Q1 		$128M Buy
3,402,263
+260,338
+8% +$10.3M 0.12% 191
2014
Q4 		$126M Buy
3,141,925
+1,050,267
+50% +$35.6M 0.12% 194
2014
Q3 		$57.8M Buy
+2,091,658
New +$50.8M 0.06% 355

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's CMRX Position: Q4 2022 in Review

UBS AM sold out of Chimerix, Inc. (CMRX) in Q4 2022, closing a stake of 84,294 shares — an estimated $163K sold.

UBS AM first reported a position in CMRX in Q3 2014 and held it in 15 quarters. The position peaked at $165M in Q2 2015. 107 funds tracked by Wall St. Rank hold CMRX as of Q4 2022.

  • UBS AM reported no remaining Chimerix, Inc. position as of Q4 2022 after selling out during the quarter.
  • UBS AM sold 84,294 Chimerix, Inc. shares in Q4 2022, an estimated $163K.
  • UBS AM first reported a position in Chimerix, Inc. in Q3 2014 and held it in 15 quarters.
  • UBS AM's Chimerix, Inc. position peaked at $165M in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.